High-mobility group box 1 (HMGB1) drives keloid pathogenesis by enhancing fibroblast proliferation, collagen synthesis, and myofibroblast differentiation, primarily through activation of RAGE-MAPK, NF-κB, and AKT signaling. The gene discussed is HMGB1; the disease is keloid.